Apply best practices to monitoring for, diagnose, and manage potential irAEs in patient with cancer receiving ICIs
This activity is intended for hematology/oncology specialists, emergency medicine physicians, and primary care physicians.
The goal of this activity is to build physician confidence in monitoring for, diagnosing, and managing immune-related adverse events (irAEs) that may occur in patients receiving immune checkpoint inhibitors (ICIs).
Approximate Time to Complete: 1 hour
Credit Available: Jan. 16, 2019 - Jan. 16, 2020
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 1.00
Accreditation Council for Continuing Medical Education (MD/DO)
AMA PRA Category 1 Credit(s)™: 1.00